Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
LifeMD Inc(LFMD)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for LFMD
10/23/2026: LFMD (1-star) is currently NOT-A-BUY. Pass it for now.
LifeMD Inc is a growing telehealth company that provides direct-to-patient virtual care and pharmacy services. The company's primary strength lies in its ability to offer an integrated experience for chronic and weight management needs, supported by a subscription-based model. Its core growth opportunity is centered on the rapid expansion of its GLP-1 weight management programs. However, the company faces risks from high customer acquisition costs, intense competition from peers like Hims & Hers, and potential regulatory scrutiny. LifeMD is best suited for growth-oriented investors who are willing to accept high volatility and monitor the company's path toward consistent profitability.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | LifeMD offers significant top-line expansion potential in the high-growth telehealth and weight management sectors. |
| Momentum investor | Mixed fit | The stock can be highly responsive to news regarding GLP-1 growth and regulatory updates, requiring a positive trend signal. |
| Value investor | Weak fit | The company is not currently focused on value metrics like P/E ratios or dividends. |
| Dividend investor | Weak fit | LifeMD does not pay a dividend. |
| Low-risk investor | Weak fit | The company's small-cap status and high volatility make it unsuitable for conservative risk profiles. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock's small-cap nature leads to significant price swings. |
| Valuation risk | Medium / high | Market expectations for growth are high, leaving little room for error. |
| Competition risk (Direct-to-Consumer Telehealth) | High | Intense competition from HIMS and other providers could compress margins. |
| Business quality | Medium | The business is scaling but lacks the long-term profitability track record of mature firms. |
| Dividend income | Low / none | The company reinvests all cash for growth. |
| Execution risk | Medium / high | The company must successfully manage complex supply chains and customer acquisition costs. |
Price Behavior
Downtrend
The stock has experienced a sustained decline in price over recent periods.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit 2.1% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/23/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 102.78M USD | Price to earnings Ratio - | 1Y Target Price 8.12 |
Price to earnings Ratio - | 1Y Target Price 8.12 | ||
Volume (30-day avg) 753.1K shares | Beta 1.99 | 52 Weeks Range 2.10 - 6.42 | Updated Date 10/25/2026 |
52 Weeks Range 2.10 - 6.42 | Updated Date 10/25/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.52 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Telehealth Subscriptions | Recurring fees from patients for access to virtual consultations and ongoing treatment plans. | Most revenue comes from patients who pay a recurring fee to stay in the program, providing predictable cash flow. |
| Pharmacy Fulfillment | Revenue generated from the sale and shipment of prescription medications to patients. | The company earns revenue by acting as a provider for the medications it prescribes. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE - | Forward PE 12.85 | Enterprise Value 313.95M | Price to Sales(TTM) 0.54 |
Enterprise Value 313.95M | Price to Sales(TTM) 0.54 | ||
Enterprise Value to Revenue 0.73 | Enterprise Value to EBITDA 36.71 | Shares Outstanding 48.26M | Shares Floating 39.66M |
Shares Outstanding 48.26M | Shares Floating 39.66M | ||
Percent Insiders 15.8 | Percent Institutions 47.59 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.